Literature DB >> 26097565

miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.

Xiao Xie1, Hong-Tao Liu2, Ju Mei1, Fang-Bao Ding1, Hai-Bo Xiao1, Feng-Qing Hu1, Rui Hu1, Ming-Song Wang1.   

Abstract

MicroRNAs are a class of small non-coding RNAs that play essential roles in cancer development and progression. Recent studies suggested that abnormal expression of miRNAs occurs frequently in non-small cell lung cancer (NSCLC) tissues compared to adjacent normal tissues. In this study, we investigated the expression and the biological roles of miR-106a in non-small cell lung cancer. Our results showed that miR-106a was up-regulated in NSCLC tissues and cell lines. Inhibition of miR-106a in NSCLC cells substantially inhibited cell proliferation, migration, and invasion. Phosphatase and tensin homolog (PTEN) was identified as a direct target of miR-106a, and over-expression of miR-106a suppressed PTEN by direct binding to its 3'-untranslated region (3'-UTR). Furthermore, the presence of miR-106a was inversely correlated with PTEN in NSCLC tissues. Overall, this study suggested that miR-106a inhibited the growth and metastasis of NSCLC cells by decreasing PTEN expression. These data provide novel insights with potential therapeutic applications for the treatment of NSCLC.

Entities:  

Keywords:  Non-small cell lung cancer; PTEN; invasion; miR-106a; migration; proliferation

Mesh:

Substances:

Year:  2015        PMID: 26097565      PMCID: PMC4466952     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

Review 1.  Physiological and pathological roles for microRNAs in the immune system.

Authors:  Ryan M O'Connell; Dinesh S Rao; Aadel A Chaudhuri; David Baltimore
Journal:  Nat Rev Immunol       Date:  2010-02       Impact factor: 53.106

Review 2.  Non-small-cell lung cancer.

Authors:  Peter Goldstraw; David Ball; James R Jett; Thierry Le Chevalier; Eric Lim; Andrew G Nicholson; Frances A Shepherd
Journal:  Lancet       Date:  2011-05-10       Impact factor: 79.321

3.  Non-small cell lung cancer.

Authors:  David S Ettinger; Wallace Akerley; Hossein Borghaei; Andrew C Chang; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Apar Kishor P Ganti; Ramaswamy Govindan; Frederic W Grannis; Leora Horn; Thierry M Jahan; Mohammad Jahanzeb; Anne Kessinger; Ritsuko Komaki; Feng-Ming Kong; Mark G Kris; Lee M Krug; Inga T Lennes; Billy W Loo; Renato Martins; Janis O'Malley; Raymond U Osarogiagbon; Gregory A Otterson; Jyoti D Patel; Mary C Pinder-Schenck; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; Scott J Swanson; Douglas E Wood; Stephen C Yang; Miranda Hughes; Kristina M Gregory
Journal:  J Natl Compr Canc Netw       Date:  2012-10-01       Impact factor: 11.908

4.  MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status.

Authors:  Guang Yang; Ruyou Zhang; Xiaofeng Chen; Yulong Mu; Jing Ai; Chen Shi; Yaohua Liu; Changbin Shi; Lihua Sun; Nikolai G Rainov; Hulun Li; Baofeng Yang; Shiguang Zhao
Journal:  J Mol Med (Berl)       Date:  2011-06-09       Impact factor: 4.599

Review 5.  PTEN loss in the continuum of common cancers, rare syndromes and mouse models.

Authors:  M Christine Hollander; Gideon M Blumenthal; Phillip A Dennis
Journal:  Nat Rev Cancer       Date:  2011-04       Impact factor: 60.716

Review 6.  The biology and clinical relevance of the PTEN tumor suppressor pathway.

Authors:  Isabelle Sansal; William R Sellers
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

7.  Cancer statistics, 2013.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-01-17       Impact factor: 508.702

Review 8.  MicroRNAs in Cancer.

Authors:  Ramiro Garzon; George A Calin; Carlo M Croce
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

Review 9.  MicroRNAs--the micro steering wheel of tumour metastases.

Authors:  Milena S Nicoloso; Riccardo Spizzo; Masayoshi Shimizu; Simona Rossi; George A Calin
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

Review 10.  Metastasis: recent discoveries and novel treatment strategies.

Authors:  Suzanne A Eccles; Danny R Welch
Journal:  Lancet       Date:  2007-05-19       Impact factor: 79.321

View more
  18 in total

1.  MicroRNA-based screens for synthetic lethal interactions with c-Myc.

Authors:  Youjun Li; Yahui Zhu; Edward V Prochownik
Journal:  RNA Dis       Date:  2016-05-30

2.  Identification of common microRNA between COPD and non-small cell lung cancer through pathway enrichment analysis.

Authors:  Amirhossein Fathinavid; Mohadeseh Zarei Ghobadi; Ali Najafi; Ali Masoudi-Nejad
Journal:  BMC Genom Data       Date:  2021-10-12

3.  MicroRNA-370 directly targets FOXM1 to inhibit cell growth and metastasis in osteosarcoma cells.

Authors:  Ning Duan; Xiaojing Hu; Xiaowei Yang; Huiguang Cheng; Wentao Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Prognostic cancer gene signatures share common regulatory motifs.

Authors:  Ying Wang; Steve Goodison; Xiaoman Li; Haiyan Hu
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

5.  Biological effects and clinical characteristics of microRNA-106a in human colorectal cancer.

Authors:  Yuzheng He; Guiqi Wang; Lei Zhang; Congjie Zhai; Jun Zhang; Xusheng Zhao; Xia Jiang; Zengren Zhao
Journal:  Oncol Lett       Date:  2017-05-16       Impact factor: 2.967

6.  A MicroRNA/Ubiquitin Ligase Feedback Loop Regulates Slug-Mediated Invasion in Breast Cancer.

Authors:  Rajesh Kumar Manne; Yashika Agrawal; Anil Bargale; Asha Patel; Debasish Paul; Neha Anilkumar Gupta; Srikanth Rapole; Vasudevan Seshadri; Deepa Subramanyam; Praveenkumar Shetty; Manas Kumar Santra
Journal:  Neoplasia       Date:  2017-05-10       Impact factor: 5.715

7.  MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN.

Authors:  Xinying Xue; Yuxia Liu; Yong Wang; Mingming Meng; Kaifei Wang; Xuefeng Zang; Sheng Zhao; Xiaohua Sun; Lei Cui; Lei Pan; Sanhong Liu
Journal:  Oncotarget       Date:  2016-12-20

8.  A three-microRNA signature for lung squamous cell carcinoma diagnosis in Chinese male patients.

Authors:  Lan Zhang; Xia Shan; Jun Wang; Jun Zhu; Zebo Huang; Huo Zhang; Xin Zhou; Wenfang Cheng; Yongqian Shu; Wei Zhu; Ping Liu
Journal:  Oncotarget       Date:  2017-07-28

9.  A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.

Authors:  Xin Zhou; Wei Wen; Jun Zhu; Zebo Huang; Lan Zhang; Huo Zhang; Lian-Wen Qi; Xia Shan; Tongshan Wang; Wenfang Cheng; Danxia Zhu; Yin Yin; Yan Chen; Wei Zhu; Yongqian Shu; Ping Liu
Journal:  Oncotarget       Date:  2017-05-23

Review 10.  MicroRNAs associated with therapy of non-small cell lung cancer.

Authors:  Junmi Lu; Yuting Zhan; Juan Feng; Jiadi Luo; Songqing Fan
Journal:  Int J Biol Sci       Date:  2018-03-10       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.